Opportunities for novel therapeutic agents acting at chemokine receptors

被引:63
作者
Saunders, J
Tarby, CM
机构
[1] Neurocrine Biosci, San Diego, CA 92121 USA
[2] CombiChem, San Diego, CA 92121 USA
关键词
D O I
10.1016/S1359-6446(98)01280-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chemokines are proinflammatory mediators that primarily control leukocyte migration into selected tissues and upregulation of adhesion:receptors. They also have a role in pathological conditions that require neovascularization and are implicated in the suppression of viral replication. By interaction with their respective G-protein-coupled receptor, chemokines have a profound influence cover the selective recruitment of specific cell types in acute inflammatory disease and, hence, inhibition of their action should be Of therapeutic benefit. Only now are small molecule inhibitors becoming available tb validate this speculation. In this review without seeking to be comprehensive, the authors provide an introduction to chemokines, their receptors and their role in certain disease processes, Also, recent disclosures claiming novel nonpeptide ligands for chemokine receptors are summarized.
引用
收藏
页码:80 / 92
页数:13
相关论文
共 109 条
  • [71] The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
    Oberlin, E
    Amara, A
    Bachelerie, F
    Bessia, C
    Virelizier, JL
    ArenzanaSeisdedos, F
    Schwartz, O
    Heard, JM
    ClarkLewis, I
    Legler, DF
    Loetscher, M
    Baggiolini, M
    Moser, B
    [J]. NATURE, 1996, 382 (6594) : 833 - 835
  • [72] Ogata H, 1997, J PATHOL, V182, P106
  • [73] Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5
    Pakianathan, DR
    Kuta, EG
    Artis, DR
    Skelton, NJ
    Hebert, CA
    [J]. BIOCHEMISTRY, 1997, 36 (32) : 9642 - 9648
  • [74] Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
    Pan, Y
    Lloyd, C
    Zhou, H
    Dolich, S
    Deeds, J
    Gonzalo, JA
    Vath, J
    Gosselin, M
    Ma, JY
    Dussault, B
    Woolf, E
    Alperin, G
    Culpepper, J
    GutierrezRamos, JC
    Gearing, D
    [J]. NATURE, 1997, 387 (6633) : 611 - 617
  • [75] PAOLINI JF, 1994, J IMMUNOL, V153, P2706
  • [76] Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice
    PlaterZyberk, C
    Hoogewerf, AJ
    Proudfoot, AEI
    Power, CA
    Wells, TNC
    [J]. IMMUNOLOGY LETTERS, 1997, 57 (1-3) : 117 - 120
  • [77] Cloning of the human eosinophil chemoattractant, eotaxin - Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils
    Ponath, PD
    Qin, SX
    Ringler, DJ
    ClarkLewis, I
    Wang, J
    Kassam, N
    Smith, H
    Shi, XJ
    Gonzalo, JA
    Newman, W
    GutierrezRamos, JC
    Mackay, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) : 604 - 612
  • [78] Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3 alpha from lung dendritic cells
    Power, CA
    Church, DJ
    Meyer, A
    Alouani, S
    Proudfoot, AEI
    ClarkLewis, I
    Sozzani, S
    Mantovani, A
    Wells, TNC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) : 825 - 835
  • [79] Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
    Proudfoot, AEI
    Power, CA
    Hoogewerf, AJ
    Montjovent, MO
    Borlat, F
    Offord, RE
    Wells, TNC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) : 2599 - 2603
  • [80] Monocyte chemoattractant protein 1 a potential regulator of monocyte recruitment in inflammatory disease
    Rollins, BJ
    [J]. MOLECULAR MEDICINE TODAY, 1996, 2 (05): : 198 - 204